News
The FDA evaluated the New Drug Application (NDA) for Joenja® under priority review and has approved the drug based on findings from a multinational, triple-blind, placebo-controlled, randomized ...
BBC on MSN1mon
Drug for rare disease brings 'joy and hope'
The newly licensed drug, leniolisib, is the first targeted treatment for her condition, Activated PI3-kinase Delta Syndrome or APDS. Not only is Mary the first patient to benefit from the drug but her ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results